Altered dimerization activity was stronger in J2 than SW15, however, cellular cytotoxicity was weaker in J2 than SW15, suggesting that J2 is expected to be more useful when combined with cytotoxic anticancer drugs including taxol, cisplatin and 17-AAG for cancer cells overexpressing HSP27. The gene discussed is HSPB1; the disease is cancer.